C-MER Medical Holdings Statistics

Total Valuation

HKG:3309 has a market cap or net worth of HKD 2.03 billion. The enterprise value is 2.14 billion.

Market Cap	2.03B
Enterprise Value	2.14B

Important Dates

The last earnings date was Thursday, May 1, 2025.

Earnings Date	May 1, 2025
Ex-Dividend Date	Jun 27, 2025

Share Statistics

HKG:3309 has 1.21 billion shares outstanding. The number of shares has decreased by -1.77% in one year.

Current Share Class	1.21B
Shares Outstanding	1.21B
Shares Change (YoY)	-1.77%
Shares Change (QoQ)	-0.92%
Owned by Insiders (%)	2.08%
Owned by Institutions (%)	3.18%
Float	504.11M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.06
PB Ratio	1.07
P/TBV Ratio	1.93
P/FCF Ratio	16.31
P/OCF Ratio	7.17
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.26, with an EV/FCF ratio of 17.18.

EV / Earnings	-15.83
EV / Sales	1.12
EV / EBITDA	6.26
EV / EBIT	16.72
EV / FCF	17.18

Financial Position

The company has a current ratio of 1.56, with a Debt / Equity ratio of 0.23.

Current Ratio	1.56
Quick Ratio	1.32
Debt / Equity	0.23
Debt / EBITDA	1.28
Debt / FCF	3.52
Interest Coverage	5.45

Financial Efficiency

Return on equity (ROE) is -5.58% and return on invested capital (ROIC) is 3.44%.

Return on Equity (ROE)	-5.58%
Return on Assets (ROA)	2.95%
Return on Invested Capital (ROIC)	3.44%
Return on Capital Employed (ROCE)	5.58%
Revenue Per Employee	937,365
Profits Per Employee	-66,224
Employee Count	2,041
Asset Turnover	0.70
Inventory Turnover	28.03

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -48.47% in the last 52 weeks. The beta is 0.78, so HKG:3309's price volatility has been lower than the market average.

Beta (5Y)	0.78
52-Week Price Change	-48.47%
50-Day Moving Average	1.62
200-Day Moving Average	2.02
Relative Strength Index (RSI)	55.23
Average Volume (20 Days)	607,400

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:3309 had revenue of HKD 1.91 billion and -135.16 million in losses. Loss per share was -0.11.

Revenue	1.91B
Gross Profit	596.90M
Operating Income	128.89M
Pretax Income	-76.22M
Net Income	-135.16M
EBITDA	202.46M
EBIT	128.89M
Loss Per Share	-0.11

Full Income Statement

Balance Sheet

The company has 467.25 million in cash and 437.79 million in debt, giving a net cash position of 29.46 million or 0.02 per share.

Cash & Cash Equivalents	467.25M
Total Debt	437.79M
Net Cash	29.46M
Net Cash Per Share	0.02
Equity (Book Value)	1.89B
Book Value Per Share	1.44
Working Capital	230.45M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 283.12 million and capital expenditures -158.62 million, giving a free cash flow of 124.51 million.

Operating Cash Flow	283.12M
Capital Expenditures	-158.62M
Free Cash Flow	124.51M
FCF Per Share	0.10

Full Cash Flow Statement

Margins

Gross margin is 31.20%, with operating and profit margins of 6.74% and -7.06%.

Gross Margin	31.20%
Operating Margin	6.74%
Pretax Margin	-3.98%
Profit Margin	-7.06%
EBITDA Margin	10.58%
EBIT Margin	6.74%
FCF Margin	6.51%

Dividends & Yields

This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 1.19%.

Dividend Per Share	0.02
Dividend Yield	1.19%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.77%
Shareholder Yield	2.96%
Earnings Yield	-6.65%
FCF Yield	6.13%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:3309 has an Altman Z-Score of 3.3.

Altman Z-Score	3.3
Piotroski F-Score	n/a